-----begin privacy-enhanced message----- proc-type: 2001,mic-clear originator-name: webmaster@www.sec.gov originator-key-asymmetric: mfgwcgyevqgbaqicaf8dsgawrwjaw2snkk9avtbzyzmr6agjlwyk3xmzv3dtinen twsm7vrzladbmyqaionwg5sdw3p6oam5d3tdezxmm7z1t+b+twidaqab mic-info: rsa-md5,rsa, g0pckbwsx1n9o/ibazbno1rzjwujdzlpaw0/7werw2n0zli8ebw6mv38ay81rlpl xnljddvy1+wbde/qg1c9xg== 0000927025-96-000038.txt : 19960513 0000927025-96-000038.hdr.sgml : 19960513 accession number:		0000927025-96-000038 conformed submission type:	sc 13d public document count:		3 filed as of date:		19960510 sros:			none subject company:	 	company data:	 		company conformed name:			microtek medical inc 		central index key:			0000763180 		standard industrial classification:	electromedical & electrotherapeutic apparatus [3845] 		irs number:				640700671 		state of incorporation:			de 		fiscal year end:			1130 	filing values: 		form type:		sc 13d 		sec act:		1934 act 		sec file number:	005-45805 		film number:		96559677 	business address:	 		street 1:		512 lehmberg rd 		city:			columbus 		state:			ms 		zip:			39702 		business phone:		6013271863 filed by:		 	company data:	 		company conformed name:			windsor capital inc 		central index key:			0001013869 		standard industrial classification:	 [] 		irs number:				430759986 	filing values: 		form type:		sc 13d 	business address:	 		street 1:		7711 bonhomme avenue 		city:			st louis 		state:			mo 		zip:			63105 		business phone:		314727766 	mail address:	 		street 1:		7711 bonhomme avenue 		city:			st louis 		state:			mo 		zip:			63105 sc 13d 1 securities and exchange commission washington, d.c. 20549 schedule 13d under the securities exchange act of 1934 microtek medical, inc. (name of issuer) common stock, par value $0.01 per share (title of class of securities) 594939100 (cusip number) windsor capital, inc. 7711 bonhomme avenue st. louis, mo 63105 attn: mr. wayne l. smith, ii (314) 727-7766 (name, address and telephone number of persons authorized to receive notices and communications) with copies to: john w. finger, esq. stinson, mag & fizzell, p.c. 100 south fourth street st. louis, mo 63102 (314)259-4500 april 30, 1996 (date of event which requires filing of this statement) if the filing person has previously filed a statement on schedule 13g to report the acquisition which is the subject of this schedule 13d, and is filing this schedule because of rule 13d-1(b)(3) or (4), check the following box [ ] check the following box if a fee is being paid with this statement [ x ] schedule 13d cusip no. 594939100 1 name of reporting person s.s. or i.r.s. identification no. of above person windsor capital, inc. 2 check the appropriate box if a member of a group (a) [ ] (b) [ ] 3 sec use only 4 source of funds pf 5 check box if disclosure of legal proceedings is required pursuant to items [ ] 6 citizenship or place of organization united states 7 sole voting power windsor capital, inc. has sole direct voting power as to 305,683 shares number of shares 8 shared voting power beneficially owned by 9 sole dispositive power reporting windsor capital, inc. has sole direct person with dispositive power as to 305,683 shares 10 shared dispositive power 11 aggregate amount beneficially owned by each reporting person 305,683 shares 12 check if the aggregate amount in row (11) excludes certain shares [ ] 13 percent of class represented by amount in row (11) 6.6% 14 type of reporting person co schedule 13d cusip no. 594939100 1 name of reporting person s.s. or i.r.s. identification no. of above person windsor, inc. 2 check the appropriate box if a member of a group (a) [ ] (b) [ ] 3 sec use only 4 source of funds af 5 check box if disclosure of legal proceedings is required pursuant to items [ ] 6 citizenship or place of organization united states 7 sole voting power number of shared indirect voting power as shares to 305,683 shares beneficially owned by 8 shared voting power reporting person with 9 sole dispositive power shared indirect dispositive power as to 305,683 shares 10 shared dispositive power 11 aggregate amount beneficially owned by each reporting person 305,683 shares 12 check if the aggregate amount in row (11) excludes certain shares [ ] 13 percent of class represented by amount in row (11) 6.6% 14 type of reporting person co schedule 13d cusip no. 594939100 1 name of reporting person s.s. or i.r.s. identification no. of above person wayne l. smith, ii 2 check the appropriate box if a member of a group (a) [ ] (b) [ ] 3 sec use only 4 source of funds af 5 check box if disclosure of legal proceedings is required pursuant to items [ ] 6 citizenship or place of organization united states 7 sole voting power number of shared indirect voting power as shares to 305,683 shares beneficially owned by 8 shared voting power reporting person with 9 sole dispositive power shared indirect dispositive power as to 305,683 shares 10 shared dispositive power 11 aggregate amount beneficially owned by each reporting person 305,683 shares 12 check if the aggregate amount in row (11) excludes certain shares [ ] 13 percent of class represented by amount in row (11) 6.6% 14 type of reporting person co schedule 13d cusip no. 594939100 1 name of reporting person s.s. or i.r.s. identification no. of above person vanessa m. tegethoff 2 check the appropriate box if a member of a group (a) [ ] (b) [ ] 3 sec use only 4 source of funds af 5 check box if disclosure of legal proceedings is required pursuant to items [ ] 6 citizenship or place of organization united states 7 sole voting power number of shared indirect voting power as shares to 305,683 shares beneficially owned by 8 shared voting power reporting person with 9 sole dispositive power shared indirect dispositive power as to 305,683 shares 10 shared dispositive power 11 aggregate amount beneficially owned by each reporting person 305,683 shares 12 check if the aggregate amount in row (11) excludes certain shares [ ] 13 percent of class represented by amount in row (11) 6.6% 14 type of reporting person co schedule 13d cusip no. 594939100 1 name of reporting person s.s. or i.r.s. identification no. of above person barney a. ebsworth 2 check the appropriate box if a member of a group (a) [ ] (b) [ ] 3 sec use only 4 source of funds af 5 check box if disclosure of legal proceedings is required pursuant to items [ ] 6 citizenship or place of organization united states 7 sole voting power number of shared indirect voting power as shares to 305,683 shares beneficially owned by 8 shared voting power reporting person with 9 sole dispositive power shared indirect dispositive power as to 305,683 shares 10 shared dispositive power 11 aggregate amount beneficially owned by each reporting person 305,683 shares 12 check if the aggregate amount in row (11) excludes certain shares [ ] 13 percent of class represented by amount in row (11) 6.6% 14 type of reporting person co item 1. security and issuer. this statement relates to the par value $0.01 per share (the "common stock"), of microtek medical, inc., a delaware corporation (the "issuer"), which has its principal executive offices at 602 lehmberg, columbus, mississippi 39702. item 2. identity and background. (a)-(c) the common stock of the issuer has been acquired by windsor capital, inc., a missouri corporation ("windsor"), having its principal business and office address at 7711 bonhomme avenue, st. louis, missouri 63105. the principal business of windsor is investments and merchant banking. the executive officers and directors of windsor and related information are provided as follows: name business principal address employment wayne l. smith, ii 7711 bonhomme avenue president, secretary st. louis, mo 63105 and sole director of windsor and windsor, inc. vanessa m. tegethoff 7711 bonhomme avenue st. louis, mo 63105 vice president--administration and assistant secretary of windsor and windsor, inc. windsor, inc. 7711 bonhomme avenue sole stockholder of st. louis, mo 63105 windsor barney a. ebsworth 7711 bonhomme avenue sole stockholder of st. louis, mo 63105 windsor, inc. (d)-(e) none of the persons with respect to whom information is provided in response to this item was, during the last five years, convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or was during the last five years, a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and therefore was not and is not subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws as a result of any such proceeding. (f) each of the natural persons with respect to whom information is provided in response to this item is a citizen of the united states. item 3. source and amount of funds or other consideration. on april 30, 1996, micro partners, l.p. ("micro partners") made a liquidating distribution of all of the shares of common stock held by micro partners to its limited partners and general partner in proportion to their respective partnership interests and in accordance with its partnership agreement. windsor is a limited partner of micro partners and therefore on april 30, 1996, became the beneficial owner of the 305,683 shares of common stock distributed to him. the shares of common stock distributed to windsor were not issued in exchange for any "funds or other consideration." item 4. purpose of transaction. with respect to the shares of common stock acquired by windsor, windsor did not acquire such shares with any particular purpose because such shares were transferred to windsor pursuant to the april 30, 1996 liquidating distribution of micro partners as described above in item 3. windsor has no present plans or proposals which would relate to or result in: (a) the acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the issuer or any of its subsidiaries; (d) any change in the present board of directors or management of issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the issuer; (f) any other material change in the issuer's business or corporate structure; (g) changes in the issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (h) causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the securities exchange act of 1934; or (j) any action similar to any of those enumerated in (a) through (i) above. it is noted, however, that the issuer and isolyser company, inc., a georgia corporation ("ici"), have entered into an agreement and plan of merger (the "merger agreement"), dated march 15, 1996, pursuant to which a subsidiary of ici has agreed, subject to certain terms and conditions, to merge into the issuer (the "merger"). in the merger, the issuer's stockholders will receive shares of ici common stock in exchange for their common stock, in accordance with the exchange ratio set forth in the merger agreement. consummation of the merger is subject to, among other things, approval by the issuer's stockholders. in connection with the parties' execution of the merger agreement, micro partners delivered a proxy to ici to vote shares of common stock held by micro partners in favor of the merger, a form of which is attached hereto as exhibit (1) and incorporated herein by reference. in addition, windsor currently intends to deliver a voting agreement to ici, a form of which is attached hereto as exhibit (2) and incorporated herein by reference, which delivers to ici a proxy with respect to all of its shares of common stock and stipulates that windsor covenants not to seek to assert any appraisal or dissenters' rights in respect of the merger. see, item 6 below. item 5. interest in securities of the issuer. (a) as of april 30, 1996, windsor held and beneficially owned 305,683 shares of common stock, which represented approximately 6.6% of the 4,596,886 shares of common stock then outstanding. (b) as of april 30, 1996, windsor's power to vote or dispose of the shares of common stock and reported as being beneficially owned by him was as follows: voting disposition common stock sole shared sole shared windsor 305,683 305,683 (c) not applicable. (d) not applicable. (e) not applicable. item 6. contracts, arrangements, understandings or relationships with respect to securities of the issuer. in connection with the parties' execution of the merger agreement, micro partners delivered a proxy to ici to vote shares of common stock held by micro partners in favor of the merger, a form of which is attached hereto as exhibit (1) and incorporated herein by reference. in addition, windsor currently intends to deliver a voting agreement to ici, a form of which is attached hereto as exhibit (2) and incorporated herein by reference, which delivers to ici a proxy with respect to all of its shares of common stock and stipulates that windsor covenants not to seek to assert any appraisal or dissenters' rights in respect of the merger. item 7. material to be filed as exhibits. the following material is filed as an exhibit to this schedule 13d: (1) agreement, dated as of march 15, 1996, by and between ici and micro partners; and (2) form of agreement to be by and among ici, micro partners and windsor. signature after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete and correct. date: may 10, 1996. windsor capital, inc. by: /s/ wayne l. smith, ii wayne l. smith, ii president windsor, inc. by: /s/ wayne l. smith, ii wayne l. smith, ii president /s/ wayne l. smith, ii wayne l. smith, ii /s/ vanessa m. tegethoff vanessa pegethoff /s/ barney a. ebsworth barney a. edsworth ex-1 2 stockholder agreement exhibit (1) agreement this agreement, dated as of march 15, 1996, is made by and between isolyser company, inc., a georgia corporation ("ici"), and micro partners, l.p. (the "stockholder"). simultaneously herewith, ici and microtek medical, inc. ("mmi") are parties to an agreement and plan of merger, dated as of the date hereof (the "merger agreement"), pursuant to which a subsidiary of ici has agreed, subject to certain terms and conditions, to merge into mmi (the "merger"). the stockholder is a member of, or has a representative on, the board of directors and/or an executive officer of mmi and has voting power with respect to the number of shares of common stock, $.01 par value ("common stock"), of mmi set forth by the stockholder's signature hereto. capitalized terms not otherwise defined herein shall have the meaning set forth in the merger agreement. at the request of and for the benefit of mmi and the other holders of shares of mmi's common stock and in order to induce ici to enter into the merger agreement and to provide reasonable assurances that the transactions contemplated by the merger agreement will be consummated, the stockholder is required to make certain agreements regarding the shares, upon the terms and subject to the conditions set forth below. accordingly, the parties hereto agree as follows: 1. voting of shares. the stockholder hereby appoints ici his/its proxy, with full power of substitution and revocation, for and in the name, place and stead of the stockholder, to vote upon and act with respect to all of the shares standing in the name of the stockholder or with respect to which the stockholder is entitled to vote and act at the mmi stockholders' meeting referenced in section 5.8 of the merger agreement, or at any adjournment thereof, and the stockholder directs that his/its proxy be voted in favor of the merger as contemplated by section 5.11(c) of the merger agreement. the stockholder hereby revokes any proxy or proxies heretofore given to vote upon or act with respect to the shares and hereby ratifies and conforms all that said proxy, its substitutes, or any of them, may lawfully do by virtue hereof. the stockholder further covenants not to seek to assert any appraisal or dissenters' right (to the extent applicable) in respect of the merger. this proxy shall be irrevocable and shall survive the death, disability or bankruptcy, or with respect to non-natural persons: the bankruptcy, merger, dissolution or liquidation, of the stockholder. notwithstanding the foregoing, this proxy shall be subject to revocation and of no further force or effect in the event that (i) the merger agreement is terminated as a result of the provisions of section 9.1(a) thereof or (ii) both (a) the merger agreement is terminated as a result of the provisions of section 9.1(f) or 9.1(g) thereof and (b) mmi has paid ici the fee set forth in section 9.2(b) of the merger agreement. 2. representation and warranties of the stockholder. the stockholder hereby represents and warrants to, and covenants with ici that: (a) the stockholder is the sole record and beneficial owner of the number of shares listed opposite such stockholder's signature hereto; no person has a right to acquire or direct the disposition, or holds a proxy or other right to vote or direct the vote, of such shares. other than this agreement and the merger agreement, there is no option, warrant, right, call, proxy, agreement, commitment or understanding of any nature whatsoever, fixed or contingent, that directly or indirectly (i) calls for the sale, pledge or other transfer or disposition of any of such stockholder's shares, any interest therein or any rights with respect thereto, or relates to the voting, disposition or control of such shares (except under pledge agreements with commercial lenders, copies of which have been furnished to ici), or (ii) obligates such stockholder to grant, offer or enter into any of the foregoing. (b) the stockholder has the full right, power, authority and legal capacity to enter into this agreement, and this agreement has been duly and validly executed and delivered by such stockholder and constitutes a valid and binding obligation of such stockholder, enforceable against such stockholder in accordance with its terms. (c) securities act representations. the stockholder hereby agrees and represents to ici that such stockholder has been advised that the offering, sale and delivery of ici common stock pursuant to the merger shall be registered under the securities act on a registration statement on form s-4. such stockholder has also been advised, however, that to the extent such stockholder is considered an "affiliate" of mmi at the time the agreement is submitted for a vote of stockholders of mmi, any public offering or sale by such stockholder of any ici common stock received by such stockholder in the merger will, under current law, require compliance with rule 145 promulgated by the sec under the securities act or the availability of another exemption from registration under the securities act. such stockholder is familiar with and agrees to comply with such requirements. such stockholder understands that ici shall place a legend on the certificate of such stockholder's ici common stock to ensure compliance with the securities act and rules thereunder. (d) pooling act representations. the stockholder will not offer to sell, transfer or otherwise dispose of any of the shares of mmi common stock or ici common stock issued to such stockholder beginning thirty (30) days prior to the closing date and continuing until such time as financial results covering a period of at least thirty (30) days of combined operations of ici and mmi have been published in accordance with section 5.10 of the agreement. 3. representations and warranties of ici. ici represents and warrants that: (a) it has the corporate power to execute, deliver and perform this agreement and to consummate the transactions contemplated hereby. (b) it has taken all corporate action necessary to authorize its execution, delivery and performance of this agreement and the consummation of the transactions contemplated hereby; and that this agreement has been duly and validly executed and delivered by ici and constitutes a valid and binding obligation of ici. 4. binding effect; assignment. this agreement shall inure to the benefit of and be binding upon the parties and their respective heirs, personal representatives, successors and permitted assigns. 5. injunctive relief; remedies cumulative. each party hereto acknowledges that the other parties will be irreparably harmed and that there will be no adequate remedy at law for a violation of any of the covenants or agreements of such party that are contained in this agreement. it is accordingly agreed that, in addition to any other remedies that may be available to the non-breaching party or parties upon the breach by any other party of such covenants and agreements, the non-breaching party or parties shall have the right to obtain injunctive relief to restrain any breach or threatened breach of such covenants or agreements or otherwise to obtain specific performance of any of such covenants or agreements. no remedy conferred upon or reserved to any party herein is intended to be exclusive of any other remedy, and every remedy shall be cumulative and in addition to every other remedy herein or now or hereafter existing at law, in equity or by statute. 6. governing law. this agreement shall be governed by and construed in accordance with the laws of the state of delaware, without regard to the law of conflicts of laws thereof. 7. counterparts. this agreement may be executed in one or more counterparts, all of which together shall constitute a single agreement. in witness whereof, each of the parties hereto has caused this agreement to be signed as of the date first above written. isolyser company, inc. by: /s/ robert taylor micro partners, l.p. by: /s/ james v. o'donnell, president of micro general, inc., its general partner [name of stockholder to be signed exactly as name appears on certificates] no. of shares: 1,742,889 ex-2 3 stockholder agreement exhibit (2) agreement this agreement, dated as of may 1, 1996, is made by and between isolyser company, inc., a georgia corporation ("ici"), micro partners, l.p. ("micro partners") and windsor capital, inc. (the "stockholder"). the stockholder has voting power with respect to the number of shares of common stock, $.01 par value ("common stock" or "shares"), of microtek medical, inc. ("mmi") set forth by the stockholder's signature hereto. on april 30, 1996, micro partners transferred those shares of common stock to the stockholder. on march 15, 1996, micro partners entered into an agreement with ici which agreement included terms substantially similar to those set forth herein. the stockholder has entered into this agreement in consideration of the distribution by micro partners to its limited and general partners of the common stock owned by micro partners. accordingly, the parties hereto agree as follows: 1. voting of shares. the stockholder hereby appoints ici his/its proxy, with full power of substitution and revocation, for and in the name, place and stead of the stockholder, to vote upon and act with respect to all of the shares standing in the name of the stockholder or with respect to which the stockholder is entitled to vote and act at the mmi stockholders' meeting referenced in section 5.8 of the agreement and plan of merger, dated march 15, 1996 (the "merger agreement"), pursuant to which a subsidiary of ici has agreed, subject to certain terms and conditions, to merge into mmi (the "merger"), or at any adjournment thereof, and the stockholder directs that his/its proxy be voted in favor of the merger as contemplated by section 5.11(c) of the merger agreement. the stockholder hereby revokes any proxy or proxies heretofore given to vote upon or act with respect to the shares and hereby ratifies and conforms all that said proxy, its substitutes, or any of them, may lawfully do by virtue hereof. the stockholder further covenants not to seek to assert any appraisal or dissenters' right (to the extent applicable) in respect of the merger. this proxy shall be irrevocable and shall survive the death, disability or bankruptcy, or with respect to non-natural persons: the bankruptcy, merger, dissolution or liquidation, of the stockholder. notwithstanding the foregoing, this proxy shall be subject to revocation and of no further force or effect in the event that (i) the merger agreement is terminated as a result of the provisions of section 9.1(a) thereof or (ii) both (a) the merger agreement is terminated as a result of the provisions of section 9.1(f) or 9.1(g) thereof and (b) mmi has paid ici the fee set forth in section 9.2(b) of the merger agreement. 2. representation and warranties of the stockholder. the stockholder hereby represents and warrants to, and covenants with ici that: (a) the stockholder is the sole record and beneficial owner of the number of shares listed opposite such stockholder's signature hereto; no person has a right to acquire or direct the disposition, or holds a proxy or other right to vote or direct the vote, of such shares. other than this agreement and the merger agreement, there is no option, warrant, right, call, proxy, agreement, commitment or understanding of any nature whatsoever, fixed or contingent, that directly or indirectly (i) calls for the sale, pledge or other transfer or disposition of any of such stockholder's shares, any interest therein or any rights with respect thereto, or relates to the voting, disposition or control of such shares (except under pledge agreements with commercial lenders, copies of which have been furnished to ici), or (ii) obligates such stockholder to grant, offer or enter into any of the foregoing. (b) the stockholder has the full right, power, authority and legal capacity to enter into this agreement, and this agreement has been duly and validly executed and delivered by such stockholder and constitutes a valid and binding obligation of such stockholder, enforceable against such stockholder in accordance with its terms. (c) securities act representations. the stockholder hereby agrees and represents to ici that such stockholder has been advised that the offering, sale and delivery of ici common stock pursuant to the merger shall be registered under the securities act on a registration statement on form s-4. such stockholder has also been advised, however, that to the extent such stockholder is considered an "affiliate" of mmi at the time the agreement is submitted for a vote of stockholders of mmi, any public offering or sale by such stockholder of any ici common stock received by such stockholder in the merger will, under current law, require compliance with rule 145 promulgated by the sec under the securities act or the availability of another exemption from registration under the securities act. such stockholder is familiar with and agrees to comply with such requirements. such stockholder understands that ici shall place a legend on the certificate of such stockholder's ici common stock to ensure compliance with the securities act and rules thereunder. (d) pooling act representations. the stockholder will not offer to sell, transfer or otherwise dispose of any of the shares of mmi common stock or ici common stock issued to such stockholder beginning thirty (30) days prior to the closing date and, to the extent the stockholder is considered an affiliate of mmi, continuing until such time as financial results covering a period of at least thirty (30) days of combined operations of ici and mmi have been published in accordance with section 5.10 of the agreement. 3. representations and warranties of ici. ici represents and warrants that: (a) it has the corporate power to execute, deliver and perform this agreement and to consummate the transactions contemplated hereby. (b) it has taken all corporate action necessary to authorize its execution, delivery and performance of this agreement and the consummation of the transactions contemplated hereby; and that this agreement has been duly and validly executed and delivered by ici and constitutes a valid and binding obligation of ici. 4. binding effect; assignment. this agreement shall inure to the benefit of and be binding upon the parties and their respective heirs, personal representatives, successors and permitted assigns. 5. injunctive relief; remedies cumulative. each party hereto acknowledges that the other parties will be irreparably harmed and that there will be no adequate remedy at law for a violation of any of the covenants or agreements of such party that are contained in this agreement. it is accordingly agreed that, in addition to any other remedies that may be available to the non-breaching party or parties upon the breach by any other party of such covenants and agreements, the non-breaching party or parties shall have the right to obtain injunctive relief to restrain any breach or threatened breach of such covenants or agreements or otherwise to obtain specific performance of any of such covenants or agreements. no remedy conferred upon or reserved to any party herein is intended to be exclusive of any other remedy, and every remedy shall be cumulative and in addition to every other remedy herein or now or hereafter existing at law, in equity or by statute. 6. governing law. this agreement shall be governed by and construed in accordance with the laws of the state of delaware, without regard to the law of conflicts of laws thereof. 7. counterparts. this agreement may be executed in one or more counterparts, all of which together shall constitute a single agreement. in witness whereof, each of the parties hereto has caused this agreement to be signed as of the date first above written. isolyser company, inc. by:_________________________ micro partners, l.p. by: micro general by:____________________ name: title: stockholder: windsor capital, inc. by:_________________________ name: title: no. of shares: -----end privacy-enhanced message----- 